Pleio Launches OLLIE: AI-Powered Solution to Enhance Human-First Medication Adherence

What You Should Know: 

– Pleio, a company known for its human-centric, peer-to-patient platform, has unveiled its latest innovation: OLLIE™. 

– The AI-powered solution is designed to deepen patient engagement, empower individuals from the outset of treatment, and establish a strong foundation for lasting behavioral treatment success. 

The Problem of Medication Non-Adherence

Medication non-adherence is a pervasive issue in healthcare, with nearly half of all patients discontinuing their prescribed medications within a year. Traditional approaches often focus on purely technological solutions, but Pleio recognizes that the key to improving adherence lies in strengthening human connection.

OLLIE’s AI-Driven Approach

OLLIE™ is centered around the patient experience, emphasizing active listening, understanding, and guiding patient conversations. By analyzing authentic interactions between patients and healthcare providers or support personnel, OLLIE™ provides crucial insights into patient sentiment, confidence levels, and emotional barriers that significantly impact medication adherence. This AI-driven approach enhances the patient experience by ensuring that every interaction is delivered with minimal friction, in a meaningful, impactful, and relevant way, all while maintaining a human touch.

How OLLIE™ Works with Pleio’s GoodStart™ Program

Pleio’s GoodStart™ program already provides valuable human-centric support to patients starting new medications. GoodStarters, who are highly trained peers within the community, engage directly with patients in a scripted environment, offering support and encouragement while equipping them with essential medication management knowledge and skills. OLLIE™ now works behind the scenes during these conversations, analyzing subtle indicators to further enhance engagement and provide even more personalized support.

Key Capabilities and Benefits of OLLIE™

• Decoding the Human Side: OLLIE™ excels at deciphering the human element of patient interactions, uncovering raw emotional reactions that may otherwise go unnoticed.
• Hyper-Personalized Engagement: These AI-powered insights ensure that patient engagement opportunities are hyper-personalized and effective.
• Actionable Insights: OLLIE™ captures the overall patient “vibe,” identifies friction points, tipping points, and preferences—key behavioral indicators that influence prescription decisions and adherence—transforming real conversational data into actionable insights.
• Patient Personas: The nuances captured by OLLIE™ are used to define patient personas based on real conversational data, enabling more targeted interventions.

“Pleio’s GoodStarters are already highly trained, empathetic peers who connect with patients in a way that truly matters,” said Michael Oleksiw, CEO at Pleio. “OLLIE takes that to the next level — it’s human connection, amplified — technology that makes our people even better at what they do best.”